Product Information
GYNAZOLE 1 2% CREAM is a brand (anda) product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $23.3038 per GM under NDC 45802039601. Its NADAC has been published 439 times since Aug 19, 2015.
FDA first approved this application on May 18, 2012.
Strength
100 mg/5g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802039601
Classification
Brand (ANDA)
Dosage Form
CREAM
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
BUTOCONAZOLE NITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200923FDA Approved
5/18/2012
On Market Since
4/29/2015
Pharmacological Classes
Price Statistics
The NADAC for GYNAZOLE 1 2% CREAM has been published 439 times since Aug 19, 2015, and over the history we have for it it has risen 75.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.3038 per GM |
|---|---|
| All-time high | $23.5488 (Oct 15, 2025) |
| All-time low | $13.2500 (Aug 19, 2015) |
| 52-week high | $23.5488 |
| 52-week low | $23.3038 |
| Median price | $20.7108 |
| Average price | $20.8623 |
| Largest weekly change | +26.3% (May 18, 2016) |
| Weeks tracked | 439 |
| Tracking since | Aug 19, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the butoconazole nitrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
butoconazole nitrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GYNAZOLE 1 2% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for GYNAZOLE 1 2% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $23.3038 per GM (NDC 45802039601), effective Sep 30, 2026.
How has the price of GYNAZOLE 1 2% CREAM changed over time?
Over the history we have for it, the NADAC for GYNAZOLE 1 2% CREAM has risen 75.9%. It has been tracked across 439 weekly CMS publications since Aug 19, 2015.
What are the highest and lowest recorded NADAC prices for GYNAZOLE 1 2% CREAM?
Since Aug 19, 2015, the NADAC for GYNAZOLE 1 2% CREAM has ranged from a low of $13.2500 (Aug 19, 2015) to a high of $23.5488 (Oct 15, 2025), with a median of $20.7108 per GM.
Are there cheaper alternatives to GYNAZOLE 1 2% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of GYNAZOLE 1 2% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GYNAZOLE 1 2% CREAM?
GYNAZOLE 1 2% CREAM (NDC 45802039601) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a brand (anda) product.